ATTY
Table 4 (cont'd)
Patient
No. & sex
Age at
surgery
Years post
exposure
Pathologic
diagnosis
Remarks
Utirik exposed
2229 F
32
15 1/2
Follicular carcinoma
Divided opinion:
2208 F
2212 F
53
53
19
19
Adenomatous nodules
Adenomatous nodules
with Hiirthle cell
Hyperplasia
2221 f°
73
19
Adenomatous nodules
with follicular
Hyperplasia, focal
atypia
2160 F
25
21 1/2
Papillary carcinoma
Hyperplasia
2150 M
2194 F
2261x M
2236 M
2193 F
2195 F
2215 F
2147
2196
2239
2132
F
F
F
F
34
59
50
35
56
22
22
23 1/2
adenoma
Follicular adenoma
Papillary carcinoma
No diagnostic lesion
Lymph node metastases
Follicular adenoma
Adenomatous nodules
Focal hyperplasia
Papillary hyperplasia
33
41
4l
Adenomatous nodule
Adenomatous nodule
Adenomatous nodules
Papillary hyperplasia
66
28
50
44
34
Papillary carcinoma
Fibrosis, hyperplasia
Adenomatous nodule
Adenomacous nodule
Fibrosis
Papillary hyperplasia
49
58
30
63
29
28
24
25 1/2
adenoma
atypical adenoma
25 1/2
25 1/2
25 1/2
26 1/2
27
27
Adenomatous nodule
Adenomatous nodules
with occult papillary
carcinoma
Adenomatous nodules
Diffuse
Adenomatous nodules
Adenomatous nodules
Adenomatous nodule
Fibrosis
Rongelap unexposed controls
¢38 F
829 F
841 F
1007
1573
867
4023
1556
M
M
F
F
F
with occult papillary
care inoma
Papillary carcinoma
No diagnostic lesion
- 65 -